穴位埋線療法聯(lián)合口服美沙拉嗪治療潰瘍性結(jié)腸炎的護(hù)理分析
發(fā)布時間:2018-06-23 來源: 感悟愛情 點擊:
摘 要:目的 分析探討護(hù)理干預(yù)對穴位埋線療法聯(lián)合口服美沙拉嗪治療潰瘍性結(jié)腸炎患者的作用。 方法 選取我院2010年8月~2013年3月診治的位于UC緩解期1周的患者62例,隨機(jī)分為美沙拉嗪組32例與美沙拉嗪聯(lián)合穴位埋線治療組(30例)聯(lián)合治療組(30例)采用穴位埋線療法并予美沙拉嗪口服,同時給予實施綜合護(hù)理干預(yù)。觀察美沙拉嗪組及聯(lián)合治療組12個月后的緩解時長、復(fù)發(fā)率以及不良反應(yīng)情況。結(jié)果 美沙拉嗪組、聯(lián)合治療組復(fù)發(fā)率分別為13(40.6%)、5(16.7%),兩組相比較P<0.05;聯(lián)合治療組的緩解時間(260±67) d比美沙拉嗪組的緩解時間(219±77) d相對較長,差異有統(tǒng)計學(xué)意義(P<0.05)。結(jié)論 護(hù)理干預(yù)對穴位埋線療法同時使用美沙拉嗪來治療潰瘍性結(jié)腸炎有積極意義,有利于減少病情復(fù)發(fā),提高患者的生活質(zhì)量。
關(guān)鍵詞:穴位埋線;潰瘍性結(jié)腸炎; 護(hù)理干預(yù)
中圖分類號:R473.5 文獻(xiàn)標(biāo)識碼:A DOI:10.3969/j.issn.1006-1959.2018.05.063
文章編號:1006-1959(2018)05-0172-02
Nursing Analysis of Acupoint Catgut Embedding Therapy Combined with Oral Mesalazine in the Treatment of Ulcerative Colitis
DU Li-jun
。―epartment of Digestive Sciences,Jiangyin Hospital,Medical College of Southeast University,Jiangyin 214400,Jiangsu,China)
Abstract:Objective To analyze the effect of nursing intervention on patients with ulcerative colitis treated by acupoint catgut embedding therapy combined with oral mesalazine.Methods In our hospital from August 2010 to March 2013 in the diagnosis and treatment of UC remission in 62 cases 1 weeks were randomly divided into the group of 32 cases and beauty of salad combined with acupoint catgut embedding therapy group(30 cases)and treatment group(30 cases)and treated with acupoint catgut embedding therapy with oral beauty of salad,and give the implementation of comprehensive nursing intervention.The length,recurrence rate and adverse reaction of mesalazine group and combined treatment group were observed after 12 months.Results The salad diazoxide group and combined treatment group recurrence rate was 13(40.6%),5(16.7%),compared with the two groups of P<0.05;the remission time of combined treatment group(260±67)d Bimei salad group remission time(219±77)d is relatively long, the difference was statistically significant(P<0.05).Conclusion Nursing intervention has a positive effect on catgut embedding therapy and mesalazine in the treatment of ulcerative colitis,which helps to reduce the recurrence and improve the quality of life of patients.
Key words:Acupoint catgut embedding;Ulcerative colitis;Nursing intervention
潰瘍性結(jié)腸炎(UC)是發(fā)生于直腸和(或)結(jié)腸的慢性非特異性炎癥性腸病的發(fā)病機(jī)制目前還未明確。二十一世紀(jì)以來,我國UC發(fā)病率的趨勢較前明顯上升,但治療藥物的發(fā)展卻無重大突破[1]。目前,UC的治療藥物主要包括腎上腺皮質(zhì)激素、氨基水楊酸制劑、生物學(xué)制劑、免疫抑制劑及腸道微生態(tài)制劑等[2]。對其治療更關(guān)注于維持緩解狀態(tài)和預(yù)防并發(fā)癥的發(fā)生,從而促進(jìn)疾病康復(fù)與提高患者的日常生活質(zhì)量,因此,在治療的同時進(jìn)行身心整體護(hù)理也十分重要。我們采用2010年8月~2013年3月穴位強(qiáng)化埋線療法聯(lián)合口服美沙拉嗪治療UC患者30例,配合必要的護(hù)理,取得良好療效,分析如下。
相關(guān)熱詞搜索:潰瘍性 穴位 口服 沙拉 結(jié)腸炎
熱點文章閱讀